BRAINSTORM CELL THERAPEUTICS INC. Short-term Debt
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Short-term Debt of $1.26 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ShortTermBorrowings · last filed 2026-08-14
- 2026-06-30: Short-term Debt $1.26M.
- 2026-03-31: Short-term Debt $1.33M.
- 2025-12-31: Short-term Debt $967.00K.
- 2025-09-30: Short-term Debt $101.00K.
| Period end | Short-term Debt |
|---|---|
| 2026-06-30 | $1.26M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.33M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $967.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $101.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $101.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.20M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $300.00K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |